S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Teva Pharmaceutical Industries SEC Filings & 10K Form (NYSE:TEVA)

$7.93
-0.10 (-1.25 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$7.68
Now: $7.93
$8.05
50-Day Range
$6.55
MA: $7.23
$8.23
52-Week Range
$6.07
Now: $7.93
$23.97
Volume27.70 million shs
Average Volume16.61 million shs
Market Capitalization$8.66 billion
P/E Ratio2.83
Dividend YieldN/A
Beta1.71

SEC Filings

Teva Pharmaceutical Industries (NYSE:TEVA) SEC Filings

DateFilerForm TypeView
10/23/2019
4:11 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
5:42 AM
Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2019
7:15 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
6:19 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:19 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:17 AM
McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:12 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:11 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
6:10 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
5:58 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
6:05 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
5:28 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:26 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:26 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:18 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:17 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:16 AM
Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:11 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:08 AM
GOLDBERG MURRAY A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:07 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:02 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:51 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
6:02 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
10:21 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
11:15 AM
Teva Pharmaceutical Industries (Filer)
Form SD
Specialized Disclosure Report  
05/21/2019
5:38 AM
de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
6:18 AM
de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
6:13 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
6:09 AM
Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
6:06 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
6:00 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
5:56 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
3:02 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
3:15 PM
Teva Pharmaceutical Industries (Filer)
Form DEFA14A
04/16/2019
3:13 PM
Teva Pharmaceutical Industries (Filer)
Form DEF 14A
04/10/2019
7:01 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2019
7:29 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:17 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:14 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:11 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:08 AM
McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:06 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:04 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:02 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
6:44 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
6:41 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
6:36 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
6:33 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
6:31 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
6:28 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:30 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:28 AM
Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:26 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:24 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:20 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:18 AM
McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:15 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:14 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:11 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:08 AM
de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:05 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:01 AM
Codner Iris Beck (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:20 AM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:36 AM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:28 AM
McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:23 AM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:16 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:10 AM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:05 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
7:35 AM
Teva Pharmaceutical Industries (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2019
6:26 AM
Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:19 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:11 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:05 AM
de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
5:58 AM
Codner Iris Beck (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
6:43 AM
de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
6:40 AM
Codner Iris Beck (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
6:36 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2019
3:20 PM
FRANKLIN RESOURCES INC (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G/A
01/03/2019
6:24 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
6:51 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
3:24 PM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
7:09 AM
Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
11:15 PM
Teva Pharmaceutical Industries (Filer)
Form EFFECT
11/26/2018
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
3:25 PM
Citibank,N.A./ADR (Filed by)
Teva Pharmaceutical Industries (Subject)
Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts  
11/07/2018
5:38 AM
McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2018
3:07 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
6:02 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:06 PM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
3:10 PM
O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
3:09 PM
Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
3:08 PM
Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
3:06 PM
Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
3:04 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2018
3:17 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
3:09 PM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel